ATGE Price Prediction Next Week
Technical Analysis
The stock shows a strong upward trend with recent consolidation near support levels. The 50-day moving average around $95 provides key support, while resistance sits at $102.
News Sentiment Analysis Recent news indicates positive momentum for ATGE:
- CEO Steve Beard is focusing on organic growth opportunities in 2025, particularly in nursing education
- Strong demand from both students and employers in the nursing sector suggests sustainable growth
- The company received a Zacks Rank #1 with increasing earnings estimates
Fundamental Strength
- P/E ratio of 17.38x is attractive compared to industry average of 23.50x
- Current year earnings estimates increased by 2.6% over the last 60 days
- Value Score of B indicates good value characteristics
Price Prediction for Next Week Based on technical indicators and positive news sentiment:
- Support level: $95
- Resistance level: $102
- Target price: $99-100
Trading Recommendation: BUY Rationale:
- Strong fundamental outlook with focus on organic growth
- Attractive valuation metrics
- Positive earnings momentum
- Technical support levels holding firm
The stock is likely to test resistance at $102 next week given the positive business outlook and CEO's growth strategy announcement. Entry around current levels with stop loss below $93 is recommended.
ATGE Similar Chart Price Prediction
The price of ATGE is predicted to go up -0.9%, based on the high correlation periods with TVE. The similarity of these two price pattern on the periods is 94.31%.
ATGE
TVE
Down: -0.9%Similarity: 94.31%
ATGE Revenue Forecast
ATGE EPS Forecast
ATGE FAQs
What is ATGE revenue forecast for next quarter？
What is ATGE eps forecast for next quarter？
ATGE Analyst's Forecast
Alexander Paris
Barrington Research
Buy
2025-01-31
Price Target
$115 → $120
Upside
+12.06%
Barrington raised the firm's price target on Adtalem Global Education to $120 from $115 and keeps an Outperform rating on the shares following the fiscal Q2 beat. The firm expects demand for healthcare professionals, which represents 90% of Adtalem's total enrollment, will continue to outpace supply for the foreseeable future.
Jeffrey Silber
BMO Capital
Buy
2024-10-30
Price Target
$84 → $90
Upside
+9.6%
